Pneumococcus still the top infectious killer of G20 children, GBD 2023 analysis finds

Even among the world's largest economies, a small group of bacteria and viruses still drives most of the infectious deaths in children — and the biggest killer remains one there has been a vaccine for since 2000. A systematic analysis published in PLOS Neglected Tropical Diseases on 17 September 2026 used the Global Burden of Disease (GBD) 2023 dataset to quantify the burden of 46 key pathogens among children aged 0-14 across the G20 countries from 1990 to 2023 [s1].

In 2023, Streptococcus pneumoniae was the leading pathogen for both deaths and lost healthy life among G20 children, accounting for approximately 66,400 deaths (95% uncertainty interval 56,400-77,000) and 5.90 million disability-adjusted life years, or DALYs (95% UI 5.01-6.85 million) [s1]. It was also the predominant pathogen behind meningitis-related burden [s1]. Klebsiella pneumoniae ranked second, causing about 21,500 deaths (95% UI 17,900-24,700), followed closely by adenovirus at about 16,700 deaths (95% UI 9,300-26,200) and rotavirus at about 16,100 deaths (95% UI 11,100-22,900) [s1].

Progress, unevenly shared

The direction of travel is downward. The authors report that the overall burden of paediatric infectious disease in G20 countries "has declined markedly since 1990," and one pathogen stands out for how fast: deaths from Haemophilus influenzae meningitis showed the most pronounced decline, an average annual reduction of 9.06% (95% confidence interval -9.98 to -8.14) [s1]. That is close to the trajectory a successful vaccine leaves behind, and Hib conjugate vaccines have been in wide use for years.

But the gains are not shared equally. Within the G20, India, South Africa and Indonesia bore the greatest burden [s1]. Age mattered as much as geography: infants younger than one year experienced substantially higher disease burdens than older children [s1]. And the study found a strong inverse relationship between a country's Socio-demographic Index — a composite of income, education and fertility — and its pathogen-attributable death rate, with a correlation coefficient of r = -0.8456 (p < 0.001) [s1]. The poorer a G20 member on that index, in short, the higher its children's risk of dying from these infections.

Why pneumococcus and rotavirus still lead

That the two diseases at the top of the list — pneumococcal disease and rotavirus — are both vaccine-preventable is the finding's sharpest edge. The authors conclude that priority should go to "increasing coverage of pneumococcal conjugate vaccines and rotavirus vaccines in resource-limited G20 settings," alongside stronger pathogen surveillance and better access to timely diagnosis and treatment of severe infections [s1]. The persistence of these deaths in some of the world's largest economies points to coverage gaps and health-system access rather than to any absence of tools.

The wider toll of childhood pneumonia sets the scale. WHO's fact sheet describes pneumonia as the single largest infectious cause of death in children worldwide, and reports that it killed 740,180 children under the age of 5 in 2019 — accounting for 14% of all deaths of children under 5 years old, but 22% of all deaths in children aged 1 to 5 years [s2]. Pneumococcus is a leading cause of that pneumonia, which is why a bacterium with a decades-old vaccine can still head a 2023 mortality ranking.

Reading a burden estimate

These figures are modelled estimates, not a death registry, and the uncertainty intervals are wide for a reason — several of the point estimates for individual pathogens span a factor of two or more, as the adenovirus range from 9,300 to 26,200 deaths shows [s1]. Attributing a child's death to a single pathogen is also genuinely hard: pneumonia and diarrhoeal and central-nervous-system infections often involve more than one organism, and GBD's attribution methods apportion the burden using statistical models rather than direct laboratory confirmation of every case. The rankings are robust; the exact counts should be read with their intervals attached. The analysis is also bounded to the G20 rather than to the world's poorest countries, so it captures the gap between rich and poor members of a single bloc rather than the far wider global inequities that fall outside it — a narrower lens than a worldwide burden estimate, but one that isolates a gap its member governments could act on.

What to watch

The study frames its own implication as an equity problem inside the G20 — a bloc that contains both the countries with the resources to close these gaps and the countries still carrying the burden. The numbers that would show whether the gap is narrowing are national coverage figures for pneumococcal conjugate and rotavirus vaccines in the lower-income G20 members, set against the child-mortality trends the GBD updates track. This analysis, echoing the site's earlier coverage of rotavirus vaccination impact, makes the case that the tools already exist; the open question is reach.

This article is informational and is not medical advice.

Sources

• Burden of 46 key pathogens among children in G20 countries, 2023: A systematic analysis and regional comparison — PLOS Neglected Tropical Diseases (Luo and colleagues), 17 September 2026
• Pneumonia in children (fact sheet) — World Health Organization